Cargando…

Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy

Botulinum neurotoxin is the therapy of choice for all forms of cervical dystonia (CD), but treatment regimens still vary considerably. The interpretation of treatment outcome is mainly based on the clinical experience and on the scientific value of the rating scales applied. The aim of this review i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jost, Wolfgang H., Hefter, Harald, Stenner, Andrea, Reichel, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2012
Materias:	Movement Disorders - Review article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575559/ https://www.ncbi.nlm.nih.gov/pubmed/22899277 http://dx.doi.org/10.1007/s00702-012-0887-7

Ejemplares similares

Selective peripheral denervation for cervical dystonia: long-term follow-up
por: Bergenheim, A Tommy, et al.
Publicado: (2015)

Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
por: Dressler, Dirk, et al.
Publicado: (2013)

Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
por: Wabbels, Bettina, et al.
Publicado: (2011)

Differences in globus pallidus neuronal firing rates and patterns relate to different disease biology in children with dystonia
por: McClelland, V M, et al.
Publicado: (2016)

Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin?
por: Kaji, Ryuji, et al.
Publicado: (2018)

Psychiatric associations of adult-onset focal dystonia phenotypes
por: Berman, Brian D, et al.
Publicado: (2017)

Rest and other types of tremor in adult-onset primary dystonia
por: Erro, Roberto, et al.
Publicado: (2014)

Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo‐controlled, randomized, double‐blinded, parallel‐group comparison/open‐label clinical trial
por: Hyodo, Masamitsu, et al.
Publicado: (2021)

Structural magnetic resonance imaging in dystonia: A systematic review of methodological approaches and findings
por: MacIver, Claire L., et al.
Publicado: (2022)

Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study
por: Berman, Brian D, et al.
Publicado: (2020)

Effect of subthalamic nucleus deep brain stimulation on dual-task cognitive and motor performance in isolated dystonia
por: Mills, Kelly A, et al.
Publicado: (2015)

The Extreme Ends of the Treatment Response Spectrum to Botulinum Toxin in Cervical Dystonia
por: Samadzadeh, Sara, et al.
Publicado: (2020)

Adult‐onset idiopathic dystonia: A national data‐linkage study to determine epidemiological, social deprivation, and mortality characteristics
por: Bailey, Grace A., et al.
Publicado: (2021)

Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension
por: Dreissen, Yasmine Emma Maria, et al.
Publicado: (2019)

Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
por: Hefter, Harald, et al.
Publicado: (2020)

Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2022)

A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis
por: Hefter, Harald, et al.
Publicado: (2011)

An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)
por: Hefter, H, et al.
Publicado: (2013)

How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Clinical relevance of neutralizing antibodies in botulinum toxin long-term treated still-responding patients with cervical dystonia
por: Hefter, Harald, et al.
Publicado: (2019)

The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia
por: Hefter, Harald, et al.
Publicado: (2021)

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
por: Sauerbier, Anna, et al.
Publicado: (2021)

Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement
por: Schramm, Axel, et al.
Publicado: (2014)

Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis
por: Hefter, Harald, et al.
Publicado: (2013)

The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia
por: Hefter, Harald, et al.
Publicado: (2020)

Thermal hypesthesia in patients with complex regional pain syndrome related dystonia
por: Munts, Alexander G., et al.
Publicado: (2010)

Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia
por: Becker, Esther B E, et al.
Publicado: (2012)

The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
por: Rittman, Timothy, et al.
Publicado: (2013)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

The differential diagnosis of Huntington's disease-like syndromes: ‘red flags’ for the clinician
por: Martino, Davide, et al.
Publicado: (2013)

The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease
por: Barker, Roger A, et al.
Publicado: (2013)

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
por: Klebe, Stephan, et al.
Publicado: (2013)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

Fetal striatal grafting slows motor and cognitive decline of Huntington's disease
por: Paganini, Marco, et al.
Publicado: (2014)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?
por: Doherty, Karen M, et al.
Publicado: (2013)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease
por: Rolinski, Michal, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l4b0a3ameihao51mmli20utuj7